Florida’s Drug Importation Plan Is Missing Cost Savings, Supply Chain Data, FDA Says
Executive Summary
Florida says new questions about its proposal show the lengths FDA will go to avoid approving it. FDA extends its deadline for acting on the application, which is the most detailed of four submitted to the agency.
You may also be interested in...
FDA To Issue Decision On Florida’s Drug Importation Proposal By October
Florida was the first of four states to submit proposals for importation of prescription drugs from Canada. PhRMA recently filed a citizen petition opposing Colorado’s proposal, which notes hurdles it is facing. Infographic compares state proposals and the drugs they plan to import.
FDA’s Orange Book Dispute Resolution Process May Grow Teeth With FTC Patent Listing Challenges
People have challenged patent listings more than 60 times in the past six years but it is up to new drug application holders to decide whether to revise or delist their submissions.
Background Music During Risk Segment Of Rx Drug Ads: FDA Explains Its Policy
Total ban on background music is unnecessary, agency says in denying KEI’s petition. FDA points to new ‘major statement’ rule and its previous letters objecting to a sponsor’s use of music in ads and says it will continue case by case analysis of ‘all of the elements’ in an ad.